Biohaven's ALS drug fails to meet study goals - Reuters

Retrieved on: 2022-09-30 09:21:15

Tags for this article:

Click the tags to see associated articles and topics

Biohaven's ALS drug fails to meet study goals - Reuters. View article details on hiswai:

Excerpt

The migraine drugmaker in May agreed to an $11.6 billion acquisition deal by Pfizer Inc , which plans to spin off its non-migraine drugs into a ...

Article found on: www.reuters.com